Nephros Inc

Nephros Inc

Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.

Stock Performance Snapshot

Strong Buy

Analyst Rating

Analysts strongly recommend buying Nephros Inc's stock due to its potential price increase.

Above Average

Financial Health

Nephros Inc. is showing good revenue growth and cash flow, indicating a solid financial position.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Baskets Featuring NEPH

Penny Stocks to Watch

Penny Stocks to Watch

Looking for the next big thing at a small price? This carefully selected group of stocks under $5 has caught the attention of professional hedge funds. These hidden gems might offer significant growth potential for investors willing to take on some risk.

Published: May 27, 2025

Explore Basket

Why You’ll Want to Watch This Stock

📈

Niche filtration demand

Products target clinical and water-purification niches where quality matters; growth depends on adoption and reimbursement, though performance can vary.

🌍

Regulatory and market access

Regulatory approvals and contractual access to hospitals or municipalities are key growth drivers; setbacks or delays can affect prospects.

Small-cap dynamics

With a modest market cap, the stock can swing widely and may have limited liquidity, so consider risk tolerance and diversify accordingly.

Why invest with Nemo?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions